|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
DE4013632A1
(de)
|
1990-04-27 |
1991-10-31 |
Max Planck Gesellschaft |
Liposomen mit positiver ueberschussladung
|
|
ATE497001T1
(de)
|
1996-12-23 |
2011-02-15 |
Immunex Corp |
Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie
|
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
|
US6274338B1
(en)
|
1998-02-24 |
2001-08-14 |
President And Fellows Of Harvard College |
Human c-Maf compositions and methods of use thereof
|
|
EA200100972A1
(ru)
|
1999-03-15 |
2002-02-28 |
Аксис Фармасьютикалз, Инк. |
Новые соединения и композиции как ингибиторы протеаз
|
|
DE60132975T2
(de)
|
2000-01-06 |
2009-02-26 |
Merck Frosst Canada Inc., Kirkland |
Neue substanzen und verbindungen als protease-inhibitoren
|
|
TR201809678T4
(tr)
|
2001-06-26 |
2018-07-23 |
Amgen Fremont Inc |
Opgl ye karşi antikorlar.
|
|
AR036375A1
(es)
|
2001-08-30 |
2004-09-01 |
Novartis Ag |
Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
|
|
GB0121033D0
(en)
|
2001-08-30 |
2001-10-24 |
Novartis Ag |
Organic compounds
|
|
KR100485271B1
(ko)
|
2002-01-16 |
2005-04-27 |
메타볼랩(주) |
전사인자 ｃ－ｍａｆ의 전사 활성 억제제로서의 니발레놀및 그를 포함하는 약제학적 조성물
|
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
DE10235624A1
(de)
|
2002-08-02 |
2004-02-19 |
Aventis Pharma Deutschland Gmbh |
Endiandric acid H und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
|
|
US20050181375A1
(en)
|
2003-01-10 |
2005-08-18 |
Natasha Aziz |
Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
|
|
CN1898563B
(zh)
|
2003-09-24 |
2011-11-23 |
肿瘤疗法科学股份有限公司 |
诊断乳腺癌的方法
|
|
AU2003286499A1
(en)
|
2003-10-17 |
2004-06-06 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Interference with c-maf function in multiple myeloma
|
|
WO2005060722A2
(en)
|
2003-12-18 |
2005-07-07 |
President And Fellows Of Hardvard College |
Modulation of immune system function by modulation of polypeptide arginine methyltransferases
|
|
TW200526224A
(en)
|
2003-12-22 |
2005-08-16 |
Alcon Inc |
Short form c-Maf transcription factor antagonists for treatment of glaucoma
|
|
EP1730308A4
(en)
|
2004-03-05 |
2008-10-08 |
Rosetta Inpharmatics Llc |
CLASSIFICATION OF BREAST CANCER PATIENTS USING A COMBINATION OF CLINICAL CRITERIA AND INFORMATIVE SKILLS
|
|
US20080131940A1
(en)
|
2004-06-25 |
2008-06-05 |
Robert Chiu |
Target Cell-Specific Short Interfering Rna and Methods of Use Thereof
|
|
WO2006135436A2
(en)
|
2004-10-22 |
2006-12-21 |
University Of Florida Research Foundation, Inc. |
Inhibition of gene expression and therapeutic uses thereof
|
|
US9134237B2
(en)
|
2005-09-20 |
2015-09-15 |
Janssen Diagnotics, LLC |
High sensitivity multiparameter method for rare event analysis in a biological sample
|
|
CA2623405C
(en)
|
2005-09-20 |
2014-11-25 |
Immunivest Corporation |
Methods and composition to generate unique sequence dna probes labeling of dna probes and the use of these probes
|
|
US20080219996A1
(en)
|
2005-09-26 |
2008-09-11 |
Thea Kalebic |
Molecular Markers Associated with Bone Metastasis
|
|
WO2008098351A1
(en)
|
2007-02-14 |
2008-08-21 |
University Health Network |
Treatment of d-cyclin mediated proliferative diseases and hemotological malignancies
|
|
EP1961825A1
(en)
|
2007-02-26 |
2008-08-27 |
INSERM (Institut National de la Santé et de la Recherche Medicale) |
Method for predicting the occurrence of metastasis in breast cancer patients
|
|
MX2009012650A
(es)
|
2007-05-24 |
2010-02-18 |
Ablynx Nv |
Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos.
|
|
CA2688049A1
(en)
|
2007-05-31 |
2008-12-04 |
Dako Denmark A/S |
Methods for utilizing esr copy number changes in breast cancer treatments and prognoses
|
|
NZ562237A
(en)
|
2007-10-05 |
2011-02-25 |
Pacific Edge Biotechnology Ltd |
Proliferation signature and prognosis for gastrointestinal cancer
|
|
AU2008314459A1
(en)
|
2007-10-18 |
2009-04-23 |
University Health Network |
Clioquinol for the treatment of hematological malignancies
|
|
WO2009114534A1
(en)
|
2008-03-14 |
2009-09-17 |
The Regents Of The University Of California |
Multi-gene classifiers and prognostic indicators for cancers
|
|
US20110144155A1
(en)
|
2008-06-06 |
2011-06-16 |
Schimmer Aaron D |
8-hydroxyquinoline derivatives for the treatment of hematological malignancies
|
|
ES2338843B1
(es)
|
2008-07-02 |
2011-01-24 |
Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas |
Huella genomica de cancer de mama.
|
|
US8642270B2
(en)
|
2009-02-09 |
2014-02-04 |
Vm Institute Of Research |
Prognostic biomarkers to predict overall survival and metastatic disease in patients with triple negative breast cancer
|
|
US20120121586A1
(en)
|
2009-05-29 |
2012-05-17 |
Astrid Kiermaier |
Modulators for her2 signaling in her2 expressing patients with gastric cancer
|
|
EP2486149B1
(en)
|
2009-08-06 |
2015-06-17 |
John Wayne Cancer Institute |
Diagnosis of primary and metastatic basal-like breast cancer and other cancer types
|
|
ES2562274T3
(es)
|
2010-10-06 |
2016-03-03 |
Fundació Institut De Recerca Biomèdica (Irb Barcelona) |
Procedimiento para el diagnóstico, pronóstico y tratamiento de metástasis de cáncer de mama
|
|
AU2012211964A1
(en)
|
2011-02-04 |
2013-08-22 |
Bioarray Genetics, Inc. |
Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment
|
|
JP5971769B2
(ja)
|
2011-03-15 |
2016-08-17 |
ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル |
アントラサイクリン療法を用いて乳癌を処置する方法
|
|
EP2780469A1
(en)
|
2011-11-18 |
2014-09-24 |
Vanderbilt University |
Markers of triple-negative breast cancer and uses thereof
|
|
EP2650682A1
(en)
|
2012-04-09 |
2013-10-16 |
Fundació Privada Institut de Recerca Biomèdica |
Method for the prognosis and treatment of cancer metastasis
|
|
EP3467124A1
(en)
|
2012-06-06 |
2019-04-10 |
Fundació Institut de Recerca Biomèdica IRB (Barcelona) |
Method for the diagnosis, prognosis and treatment of lung cancer metastasis
|
|
CA2888122A1
(en)
|
2012-10-12 |
2014-04-17 |
Inbiomotion S.L. |
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf
|
|
US10119171B2
(en)
|
2012-10-12 |
2018-11-06 |
Inbiomotion S.L. |
Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
|
|
KR20150122786A
(ko)
|
2013-03-15 |
2015-11-02 |
펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) |
암 전이의 진단, 예후 및 치료를 위한 방법
|
|
US20160032399A1
(en)
|
2013-03-15 |
2016-02-04 |
Inbiomotion S.L. |
Method for the Prognosis and Treatment of Renal Cell Carcinoma Metastasis
|
|
US20160032400A1
(en)
|
2013-03-15 |
2016-02-04 |
Fundació Institut De Recerca Biomèdica (Irb Barcelona) |
Method for the prognosis and treatment of cancer metastasis
|
|
EP3524698A1
(en)
|
2013-10-09 |
2019-08-14 |
Fundació Institut de Recerca Biomèdica IRB (Barcelona) |
Method for the prognosis and treatment of cancer metastasis
|
|
KR20170093182A
(ko)
|
2014-12-11 |
2017-08-14 |
인바이오모션 에스.엘. |
인간 c-maf에 대한 결합 구성원
|
|
CA3025264A1
(en)
|
2016-05-25 |
2017-11-30 |
Inbiomotion S.L. |
Therapeutic treatment of breast cancer based on c-maf status
|
|
EP3296431A1
(en)
|
2016-09-15 |
2018-03-21 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Method of synthesis of an electrode for use as a catalyst of oxygen evolution reaction
|
|
CA3082728A1
(en)
|
2017-11-22 |
2019-05-31 |
Inbiomotion S.L. |
Therapeutic treatment of breast cancer based on c-maf status
|